News: Oregon’s Bio Boom – ‘Pandemic ready’ industry surpasses $15b footprint creating more firms, more jobs, more investment, more discovery, more innovation

Oregon Bioscience Association released its new economic impact report (posted here) at which points to continued robust growth during the pandemic, with combined economic impacts far outpacing Oregon’s overall economy. Separately, venture capital investment in Oregon and southwest Washington health firms skyrocketed in 2021.

(Portland, Ore. – June 15, 2022) – ‘New’ money flowing to Oregon’s and southwest Washington’s biotech firms and life science research organizations hit its zenith in 2020.


Opinion: How the vaccine has made it all over the world

This commentary, “Opinion: How the vaccine has made it all over the world,” authored by Oregon Bio’s 2022 Chair Dan Snyder, recently ran in the Portland Tribune.

The barriers to people in developing countries getting vaccinated against Covid-19 is decidedly not supply.

Last week, Africa requested all Covid-19 vaccine donations be paused until the third or fourth quarter of this year. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, said the primary challenge for vaccinating the continent is […]


Dr. Emmanuel Akporiaye joins the Oregon Bio board

The Oregon Bioscience Association is pleased to announce that Dr. Akporiaye has joined its Board of Directors

Dr. Emmanuel Akporiaye has over 35  years of experience as a cancer researcher.  His research efforts have focused on understanding the interactions between cancer cells and immune cells that favour tumor growth and spread, and developing novel therapies that are safe, effective, and less toxic while at the same time ensuring that the patient’s quality of life is not compromised. In 2012, Dr. Akporiaye […]


Voice of Industry with OHSU’s Tech Transfer leader

Travis G. Cook recently met with Oregon Bio to discuss OHSU’s tech transfer initiatives. He’s the senior director of Technology Transfer at Oregon Health & Science University, champions research and development by promoting an innovative and entrepreneurial culture.  Prior to OHSU, he served as director of business development at Galena Biopharma (Nasdaq: GALE), an adjunct professor at University of Portland bringing concepts of tech commercialization in the school’s Technology Entrepreneurship Certification program with previous appointments at Kalypsys, Inc., Ansata Therapeutics, […]


Oregon Bio – 2021: What a year!

Year in Review with Liisa Bozinovic, Executive Director, Oregon Bioscience Association

2021 was a year of change at the Oregon Bioscience Association for #ORBioMembers as well as the industry on a regional and global level. We’re counting success by the numbers and by outcomes that grew the industry and ensured our members’ successes.

What a year it was! The region’s first bio […]


Regional biotech and health firms raked in record investments in 2021

Regional biotech firms had a record year in VC, as reported by the Portland Business Journal on 1/10/2022.

Venture capital poured into the Oregon and Southwest Washington biotech sector in 2021, with investments blasting past the two previous years.

All told, there was about $324 million in VC investments in biotech and digital health companies last year, according to data compiled by PitchBook and The Business Journal. That’s up from $173 million in 2020 and $87 million in 2019 and appears to […]


Voice of Industry: MSEI/BIOTRONIK is in expansion mode and hiring; “always expanding our talent”

For this Voice of Industry article, Oregon Bio recently reached out to MSEI and BIOTRONIK, two connected and growing research, development, design and technology companies with North American headquarters in Lake Oswego, Oregon and with 450+ employees, to learn more about growth plans and new strategies going in 2022.

We queried Juergen Lindner, General Manager at MSEI (Micro Systems Engineering, Inc.) and member of Oregon Bio’s Board of Directors about the emerging opportunities for one of Oregon’s largest biotech employers.

Question: […]


Voice of Industry: How Aronora is developing ‘paradigm-shifting therapies’

Erik I. Tucker

Oregon Bio recently talked with Erik I. Tucker, Ph.D., president and CEO of Aronora, Inc., a clinical stage biotechnology company developing paradigm-shifting therapies for serious hematologic diseases. Aronora launched and is headquartered in Portland and we recently heard some of Dr. Tucker’s wisdom.

Q. What is Aronora’s mission?
Aronora is a clinical stage biopharmaceutical company with a mission to develop safe, paradigm-shifting drugs to treat life-threatening blood diseases. We have three drug […]


News: Industry collab as Oregon Bio and Onward Eugene announce development partnership to grow jobs and biotech in the Willamette Valley

Industry collab: Oregon Bio and Onward Eugene announce development partnership to grow jobs and biotech in the Willamette Valley

(Dec. 3, 2021)  – More than 100 biotech and life science companies, labs and startups in Lane County  – and those yet to be – are sharing in today’s exciting announcement that  the Oregon Bioscience Association and Onward Eugene are formally partnering to accelerate the growth of the bioscience industry in the region.

Oregon Bioscience Association and Onward Eugene yesterday […]


Voice of Industry: Q&A with Skanska about building the future of healthcare

We recently connected with Skanska USA Building’s Vice President and Account Manager Todd Predmore, an Oregon Bio board member, to discuss how the global construction management company is working in the Pacific Northwest to shape the future of health technology, R&D and care.

Q: What capabilities are needed now to build cutting-edge health and technology facilities in the Pacific Northwest?

A:  Design and construction in the life sciences sector has long been a core […]